Prior Red Blood Cell Transfusions in Cancer Patients Increase the Risk of Subsequent Transfusions With or Without Recombinant Human Erythropoietin Management

2005 ◽  
Vol 10 (1) ◽  
pp. 63-71 ◽  
Author(s):  
F. Couture ◽  
A.R. Turner ◽  
B. Melosky ◽  
L. Xiu ◽  
R.K. Plante ◽  
...  
2020 ◽  
Vol 13 (2) ◽  
pp. 760-763
Author(s):  
Majd M. Aldwairi ◽  
Mohamed A. Yassin

Iron overload is a common complication in patients with chronic renal failure treated with dialysis prior to the availability of recombinant human erythropoietin therapy. Iron overload was the result of hypoproliferative erythroid marrow function coupled with the need for frequent red blood cell transfusions to manage symptomatic anemia. The repetitive use of intravenous iron with or without the use of red blood cell transfusions also contributed to iron loading and was associated with iron deposition in liver parenchymal and reticuloendothelial cells. Here we report a 56-year-old female with end-stage renal failure who underwent kidney transplant twice and found to have iatrogenic iron overload with excess intravenous iron treated conservatively.


Author(s):  
Reinhard Schmidt ◽  
Dietmar Lerche ◽  
Erhard D�rp ◽  
Roland Winkler ◽  
Horst Klinkmann

2016 ◽  
Vol 25 (3) ◽  
pp. 973-982
Author(s):  
Elisabeth Luporsi ◽  
Alain Toledano ◽  
Dominique Spaeth ◽  
Florian Scotté ◽  
Marc Espié ◽  
...  

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 20623-20623
Author(s):  
B. L. Nordstrom ◽  
K. H. Fraeman ◽  
W. Luo ◽  
J. M. Collins ◽  
C. D. O’Malley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document